NASAL POLYPS
Clinical trials for NASAL POLYPS explained in plain language.
Never miss a new study
Get alerted when new NASAL POLYPS trials appear
Sign up with your email to follow new studies for NASAL POLYPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug 611 shows promise for stubborn nasal polyps in phase 3 trial
Disease control OngoingThis study tests a new medicine called 611 in 243 adults with chronic sinusitis and nasal polyps that haven't been well-controlled by other treatments. The goal is to see if 611 can shrink polyps and ease nasal congestion over 24 weeks. Participants receive either 611 or a placeb…
Matched conditions: NASAL POLYPS
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 12:59 UTC
-
New hope for aspirin-sensitive asthma and polyp sufferers: dupilumab study reveals how it works
Disease control OngoingThis study looks at how the drug dupilumab helps people with aspirin-exacerbated respiratory disease (AERD), a condition that includes asthma, nasal polyps, and reactions to aspirin. Seventeen adults with AERD and impaired smell will receive dupilumab for 8 weeks. Researchers wil…
Matched conditions: NASAL POLYPS
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Smaller procedure for nasal polyps could mean faster recovery
Symptom relief OngoingThis study tests a smaller surgical procedure done in the clinic for people with chronic sinusitis and nasal polyps. The goal is to see if it works as well as standard surgery in the operating room, with benefits like shorter recovery and lower cost. The study will check how many…
Matched conditions: NASAL POLYPS
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC